Climate change anxiety is pushing Americans toward collective climate action

New research reveals that while climate anxiety drives many Americans to take action on climate change, those with severe distress may struggle to engage, highlighting the need for mental health support in the fight against environmental threats.

Cognition Therapeutics’ stock sinks on Phase 2 Alzheimer’s data

New Alzheimer’s data from Cognition Therapeutics appeared to show an early drug effect, but one that lessened over time. Cognition presented Phase 2 results from

July 30, 2024

LabCentral, a crucial incubator for local drug discovery, is slated to grow amid industry slowdown

CAMBRIDGE — Vietnamese-born entrepreneur Jean Pham is “graduating” from LabCentral, a biotech launchpad on the edge of Kendall Square, after enjoying free lab space for

January 2, 2024

Fragmented sleep in midlife linked to poorer cognitive function a decade later

People who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later, according

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.